Treatment With Local PPARgamma Ligand in Distal Ulcerative Colitis
Phase of Trial: Phase I/II
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Rosiglitazone (Primary) ; Mesalazine
- Indications Ulcerative colitis
- Focus Biomarker; Therapeutic Use
- 19 Jan 2010 Primary endpoint 'Mayo score' has been met.
- 19 Jan 2010 Status changed from active, no longer recruiting to completed according to results published in The American Journal of Gastroenterology.
- 19 Jan 2010 Results have been published in The American Journal of Gastroenterology.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History